186 related articles for article (PubMed ID: 36919714)
1. Development and validation of robust metabolism-related gene signature in the prognostic prediction of hepatocellular carcinoma.
Pan Y; Zhang D; Chen Y; Li H; Wang J; Yuan Z; Sun L; Zhou Z; Chen M; Zhang Y; Hu D
J Cell Mol Med; 2023 Apr; 27(7):1006-1020. PubMed ID: 36919714
[TBL] [Abstract][Full Text] [Related]
2. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of metabolism-related gene signature in prognostic prediction of gastric cancer.
Luo T; Li Y; Nie R; Liang C; Liu Z; Xue Z; Chen G; Jiang K; Liu ZX; Lin H; Li C; Chen Y
Comput Struct Biotechnol J; 2020; 18():3217-3229. PubMed ID: 33209209
[TBL] [Abstract][Full Text] [Related]
4. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Yang Z; Zi Q; Xu K; Wang C; Chi Q
Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
[TBL] [Abstract][Full Text] [Related]
5. A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma.
Chen J; Wang H; Zhou L; Liu Z; Chen H; Tan X
Cancer Med; 2022 Dec; 11(24):5079-5096. PubMed ID: 35560794
[TBL] [Abstract][Full Text] [Related]
6. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
8. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma.
Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Shi N; Jin H
J Clin Lab Anal; 2021 Nov; 35(11):e24005. PubMed ID: 34523732
[TBL] [Abstract][Full Text] [Related]
9. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
[TBL] [Abstract][Full Text] [Related]
10. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
Zhen Z; Shen Z; Hu Y; Sun P
Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
[TBL] [Abstract][Full Text] [Related]
11. m
Li W; Liu J; Ma Z; Zhai X; Cheng B; Zhao H
Dis Markers; 2021; 2021():8859590. PubMed ID: 34234878
[TBL] [Abstract][Full Text] [Related]
12. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
Wang Y; Song F; Zhang X; Yang C
Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.
Wang X; Xing Z; Xu H; Yang H; Xing T
Aging (Albany NY); 2021 Apr; 13(10):13822-13845. PubMed ID: 33929972
[TBL] [Abstract][Full Text] [Related]
15. Exploration and validation of the prognostic value of RNA-binding proteins in hepatocellular carcinoma.
Wang J; Han K; Li Y; Zhang C; Cui WH; Zhu LH; Luo T; Bian CJ
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8945-8958. PubMed ID: 36524514
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a RNA binding protein gene pair-associated prognostic signature for prediction of overall survival in hepatocellular carcinoma.
Kang C; Jia X; Liu H
Biomed Eng Online; 2020 Sep; 19(1):68. PubMed ID: 32873282
[TBL] [Abstract][Full Text] [Related]
17. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
[TBL] [Abstract][Full Text] [Related]
18. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a coagulation-related genes prognostic model for hepatocellular carcinoma.
Yang WX; Gao HW; Cui JB; Zhang AA; Wang FF; Xie JQ; Lu MH; You CG
BMC Bioinformatics; 2023 Mar; 24(1):89. PubMed ID: 36894886
[TBL] [Abstract][Full Text] [Related]
20. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
